
Phospho-SLAM/CD150 (Tyr281) Rabbit Polyclonal Antibody#abs140341
Please note that the price mentioned above is only for your reference. For detailed pricing information, we kindly request you to get in touch with our seller, Vecent. Western blot analysis SLAM/CD150 (Phospho-Tyr281) using UV treated HeLa whole cell lysates This product is for research use...
Description
| Catalog-specification | Delivery time | USD price |
abs140341-100ug | 1-2 Weeks | 301.0 |
abs140341-50ug | 1-2 Weeks | 201.0 |
Please note that the price mentioned above is only for your reference. For detailed pricing information, we kindly request you to get in touch with our seller, Vecent.
| Overview | |
catalog | abs140341 |
| Other names | CD150, also known as signaling lymphocytic activation molecule (SLAM) family member 1, is a protein encoded by the CD150 gene. It is also referred to as CDw150, Estm51, Ipo3, MGC151472, MGC151476, OTTHUMP00000025670, OTTHUMP00000060252, RGD1560634, Slaf1, SLAF1_HUMAN, Slamf 1, or SLAMF1. CD150 is a member of the SLAM family, involved in signaling lymphocytic activation. It plays a crucial role in immune responses and cellular communication. The protein exists as different isoforms, such as isoform CRA_a and isoform CRA_b, which contribute to its diverse functions. The CD150 antigen is expressed on various immune cells, including T cells, B cells, and natural killer cells. It interacts with specific ligands on target cells, triggering signaling pathways that regulate immune cell activation, differentiation, and cytotoxicity. The precise mechanisms underlying the functions of CD150 are still being investigated, but studies have shown its involvement in the regulation of immune cell proliferation, cytokine production, and antibody production. It is also implicated in the pathogenesis of certain diseases, including viral infections, autoimmune disorders, and cancers. Given the essential role of CD150 in immune responses, further research is warranted to explore its potential as a therapeutic target for immunomodulation and the development of novel treatments for immune-related diseases. |
| Source | Rabbit |
| Specificity | The antibody SLAM/CD150 (Phospho-Tyr281) is capable of detecting only the phosphorylated form of SLAM/CD150 at Tyr281, at levels that are naturally present within the cell. |
| Species Reactivity | Human;Mouse |
| Predictive reaction species | Bovine;Pig;Sheep |
| Antigen | SLAM/CD150 |
| Application | WB 1:1000-3000, ELISA(peptide) 1:20000-1:40000 |
| Immunogen | A peptide has been synthesized that is based on human SLAM/CD150, specifically targeting the phosphorylation site at Tyr281. The peptide is designed to closely resemble the original molecule, and may have applications in a variety of biomedical research fields. By utilizing cutting-edge techniques in peptide synthesis and analysis, scientists can create highly specific and effective therapies that can help treat a range of diseases and conditions. Overall, this synthesized peptide represents an exciting development in the field of biotechnology, and holds promise for advancing our understanding of human health and disease. |
| MW | 70kDa |
| Properties | |
Concentration | 1mg/ml |
| purification | The purified rabbit serum yielded the antibody through a process of sequential chromatography, with separate affinity columns used for phospho- and non-phospho-peptides. This ensured high quality and specificity in the resulting product. |
| Clonality | Polyclonal Antibody |
| Stability & Storage | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles |
| Storage buffer | Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt. |
Target | |
Background | Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. SLAMF1-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAMF1 signaling seem to exist: one depending on SH2D1A (and perhaps SH2D1B) and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates. Initially it has been proposed that association with SH2D1A prevents binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2 (PubMed:11806999). However, signaling is also regulated by SH2D1A which can simultaneously interact with and recruit FYN which subsequently phosphorylates and activates SLAMF1 (PubMed:12458214). Mediates IL-2-independent proliferation of activated T-cells during immune responses and induces IFN-gamma production (By similarity). Downstreaming signaling involves INPP5D, DOK1 and DOK2 leading to inhibited IFN-gamma production in T-cells, and PRKCQ, BCL10 and NFKB1 leading to increased T-cell activation and Th2 cytokine production (By similarity). Promotes T-cell receptor-induced IL-4 secretion by CD4+ cells (By similarity). Inhibits antigen receptor-mediated production of IFN-gamma, but not IL-2, in CD4-/CD8- T-cells (By similarity). Required for IL-4 production by germinal centers T follicular helper (T(Fh))cells (By similarity). May inhibit CD40-induced signal transduction in monocyte-derived dendritic cells (PubMed:16317102). May play a role in a allergic responses and may regulate allergen-induced Th2 cytokine and Th1 cytokine secretion (By similarity). In conjunction with SLAMF6 controls the transition between positive selection and the subsequent expansion and differentiation of the thymocytic natural killer T (NKT) cell lineage. Involved in the peripheral differentiation of indifferent natural killer T (iNKT) cells toward a regulatory NKT2 type (By similarity). In macrophages involved in down-regulation of IL-12, TNF-alpha and nitric oxide in response to lipopolysaccharide (LPS) (By similarity). In B-cells activates the ERK signaling pathway independently of SH2D1A but implicating both, SYK and INPP5D, and activates Akt signaling dependent on SYK and SH2D1A (By similarity). In B-cells also activates p38 MAPK and JNK1 and JNK2 (PubMed:20231852). In conjunction with CD84/SLAMF5 and SLAMF6 may be a negative regulator of the humoral immune response (By similarity). |
| Tissue specificity | Constitutively expressed on peripheral blood memory T-cells, T-cell clones, immature thymocytes and a proportion of B-cells, and is rapidly induced on naive T-cells after activation (PubMed:7617038). Activated B-cells express isoform 1, isoform 3 and a cytoplasmic isoform (PubMed:9091591). Isoform 4 is expressed in B-cells, primary T-cells, dendritic cells and macrophages. Isoform 4 is expressed in tumors of the central nervous system (PubMed:25710480). |
| Posttranslational modification | Phosphorylated on tyrosine residues by FYN. |
| Celluar localization | Extracellular region or secreted;Plasma Membrane; |
| UniPort | Q13291 |

Western blot analysis SLAM/CD150 (Phospho-Tyr281) using UV treated HeLa whole cell lysates
This product is for research use only, not for use in diagnostic prodecures or in human.
Hot Tags: phospho-slam/cd150 (tyr281) rabbit polyclonal antibody#abs140341, China phospho-slam/cd150 (tyr281) rabbit polyclonal antibody#abs140341 suppliers
Send Inquiry
You Might Also Like






